Newly-approved abortifacient to be dispensed without risk assessment,
possibly over the counter

The controversial early abortion drug Preven, a so-called “emergency contraceptive,” was put on the Canadian market Sept. 17. Furthermore, plans are underway to have the drugs available over the counter in short order.

Sales representatives from Roberts Pharmaceuticals, the Oakville, Ont. agency which has exclusive Canadian marketing rights to Preven (from Gynetics Inc., its U.S. manufacturer), have been approaching pharmacists with information on the drug’s availability. Promotional material notes that Roberts plans “an aggressive national promotion campaign” for the early abortion kit.

Despite assurances from Health Canada that the drug would only be available by prescription, the Canadian Pharmacists Association (CPhA) has, in conjunction with the Society of Obstetricians and Gynaecologists of Canada (SOGC), devised a plan whereby the “emergency contraception” would be available without seeing a doctor. The July/August edition of the Canadian Pharmaceutical Journal unveiled an elaborate plan whereby pharmacists would receive training and appropriate compensation in order to “prescribe” the abortifacient kit directly without recourse to a physician.

The SOGC says that the impetus for making the drugs available over the counter comes from the United Nations’ health arm, the World Health Organization. Rosemary Killeen, SOGC director of professional affairs justified the SOGC support for the over the counter availability of the drug saying, “The World Health Organization has made a statement (that) a pelvic exam is not required to prescribe emergency contraception.”

The same deceptive marketing campaign that is being waged in the U.S. to hide the truth of the abortifacient nature of the morning-after pills is prevalent in Preven’s marketing in Canada. The ads portray them as true contraceptives rather than abortifacients.

A large portion of the deception stems from the altered definition of “pregnancy” used by the “emergency contraception” pushers. While pregnancy commences at fertilization (conception), those bent on pushing the drugs have conveniently redefined pregnancy as beginning at implantation. Thus Preven and all such morning-after pills bring about the death of the human embryo by altering the lining of the womb so as to make it unable to support the embryo.

Textbooks on embryology state clearly: “After fertilization, the pre-implantation embryo remains extremely vulnerable. The ‘morning after’ pill, with its high estrogen content, alters the endometrium so that implantation fails to occur …” (Human Embryology and Developmental Biology, by Bruce M. Carlson, M.D., Ph.D., 1994, p. 110.)

Apart from the side-effects of the pill, such as severe nausea and vomiting, studies have shown use of the drugs to be strongly associated with breast cancer, cervical cancer, blood clots, infertility, strokes and ectopic pregnancies. In fact the reason for the switch from the original birth-control pill to the “mini-pill,” containing a lower dosage of hormones, was specifically to avoid the nasty side-effects of the original pill’s high hormone levels. The morning-after pills, however, are a quadruple dose of a pill with a much higher hormone dose than a regular mini-pill and thus likely to produce worrisome side-effects.

The U.S. marketing of Preven has met with strong resistance from pro-life forces, and lawsuits from pharmacists with conscientious objections. Judie Brown of American Life League referred to Preven as “a do-it-yourself abortion kit.”

In Canada, Pharmacists for Life says pro-life pharmacists are concerned over having to dispense abortion-causing drugs and the organization hopes that conscience legislation will be enacted to protect the beliefs of pharmacists.

Andrew Peltier, public relations director for Wal-Mart Canada, says that Wal-Mart pharmacies in Canada will not be stocking Preven. The Hamilton Spectator reported Nov. 13 that three pharmacies in the Hamilton Ont. area have either refused to carry Preven or have promised their employees will not be forced to dispense the drug against their conscientious objections.

The approval of Preven in Canada has also led to a boycott of the company marketing it in this country, Roberts Pharmaceuticals. Campaign Life Coalition plans to list several of the company’s products in an upcoming newsletter to pro-lifers across the country.